These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 8536215)
21. Action of 2-beta-d-Ribofuranosylthiazole-4-carboxamide (tiazofurin) in Chinese hamster ovary and variant cell lines. Saunders PP; Kuttan R; Lai MM; Robins RK Mol Pharmacol; 1983 Mar; 23(2):534-9. PubMed ID: 6188036 [TBL] [Abstract][Full Text] [Related]
22. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice. Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601 [TBL] [Abstract][Full Text] [Related]
23. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol. Madari H; Panda D; Wilson L; Jacobs RS Cancer Res; 2003 Mar; 63(6):1214-20. PubMed ID: 12649179 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene. Yang DC; Jiang XP; Elliott RL; Head JF Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259 [TBL] [Abstract][Full Text] [Related]
25. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma. Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891 [TBL] [Abstract][Full Text] [Related]
26. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A. Ueno NT; Yu D; Hung MC Oncogene; 1997 Aug; 15(8):953-60. PubMed ID: 9285690 [TBL] [Abstract][Full Text] [Related]
27. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. Shen F; Xue X; Weber G Anticancer Res; 1999; 19(3A):1657-62. PubMed ID: 10470097 [TBL] [Abstract][Full Text] [Related]
28. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach. Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974 [TBL] [Abstract][Full Text] [Related]
29. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024 [TBL] [Abstract][Full Text] [Related]
30. Difluoromethylornithine antagonizes taxol cytotoxicity in MCF-7 human breast cancer cells. Das B; Rao AR; Madhubala R Oncol Res; 1997; 9(11-12):565-72. PubMed ID: 9563003 [TBL] [Abstract][Full Text] [Related]
31. Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy. MÃ¥rlind J; Kaspar M; Trachsel E; Sommavilla R; Hindle S; Bacci C; Giovannoni L; Neri D Clin Cancer Res; 2008 Oct; 14(20):6515-24. PubMed ID: 18927291 [TBL] [Abstract][Full Text] [Related]
32. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691 [TBL] [Abstract][Full Text] [Related]
33. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Foroodi F; Duivenvoorden WC; Singh G Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028 [TBL] [Abstract][Full Text] [Related]
34. Activation of the sphingomyelin cycle by brefeldin A: effects of brefeldin A on differentiation and implications for a role for ceramide in regulation of protein trafficking. Linardic CM; Jayadev S; Hannun YA Cell Growth Differ; 1996 Jun; 7(6):765-74. PubMed ID: 8780890 [TBL] [Abstract][Full Text] [Related]
35. The mode of action of taxol: apoptosis at low concentration and necrosis at high concentration. Yeung TK; Germond C; Chen X; Wang Z Biochem Biophys Res Commun; 1999 Sep; 263(2):398-404. PubMed ID: 10491305 [TBL] [Abstract][Full Text] [Related]
36. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196 [TBL] [Abstract][Full Text] [Related]
37. Amplification of signal transduction capacity and down-regulation by drugs. Weber G; Shen F; Yang H; Prajda N; Li W Adv Enzyme Regul; 1999; 39():51-66. PubMed ID: 10470366 [TBL] [Abstract][Full Text] [Related]
38. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Singh TR; Shankar S; Chen X; Asim M; Srivastava RK Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373 [TBL] [Abstract][Full Text] [Related]
39. The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells. Seidman R; Gitelman I; Sagi O; Horwitz SB; Wolfson M Exp Cell Res; 2001 Aug; 268(1):84-92. PubMed ID: 11461121 [TBL] [Abstract][Full Text] [Related]
40. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review. Holmes FA Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]